LexaGene unveiled the LX2 prototype design to a veterinary diagnostics audience on October 20th, 2018 at the AAVLD Annual Meeting in Kansas City. LX2 Prototype design; Unveiling at Booth 203 by CEO Dr. Jack Regan; Veterinary diagnosticians engaging with LX2 technology.
See how rapid, point-of-care molecular diagnostics could have improved patient outcome. Read the story of how Nancy the Dachshund did not receive the correct treatment due to the lag-time to receive lab results, and how LexaGene’s LX6 could have prevented this scenario.
LexaGene describes the technology behind our fully automated, open access pathogen detection device, the LX6.
Imagine anyone collecting a raw sample, loading it onto a fully automated instrument and getting a genetic result in about 1 hour.
These annotated images show the basics of how our technology works. The LX6 is the first automated pathogen detection system of its kind.
At a conference in July 2017, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.